Skyscape Web Viewer : EBMG: Diabetes and Endocrinology : Primary Index

View All
Dopamine agonists
Dopamine agonist
Dopamine antagonists A Patient with Drug Addiction in Primary Care - Related Resources Dopamine Agonists for Cocaine Dependence Drugs for Intraoperative and Postoperative Nausea and Vomiting Treatment of Drug Addicts - Related Resources
Dopamine
Doping in Sports
Doping
Doppler stethoscope
Doppler ultrasound
Doppler
Dornase alfa
Dorsal avulsion Extension Splint Mallet Finger
Dosage
Dose-dispensing units
Dose-Response Relationship, Drug
Dose
Dosing intensity
DOT
Double gloving
Double intrauterine insemination
Down's Syndrome
Down syndrome
Down-titration Downtitration and Discontinuation Strategies of Tnf-Blocking Agents in Rheumatoid Arthritis Inhaled Beclomethasone Versus Budesonide for Chronic Asthma
Doxazosin
Doxepin Antidepressants for Co-Occurring Depression and Alcohol Dependence Antidepressants for Insomnia in Adults Interventions for Fatigue in Parkinson's Disease Pharmacological Interventions for Clozapine-Induced Hypersalivation Pharmacological Interventions for Uraemic Pruritus in Adult Palliative Care Patients
Doxorubicin
Doxycycline
D-penicillamine
DPP4 inhibitors Incretin-Based Therapy with Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes Oral Antidiabetic Drugs and GLP-1 Analogues in the Treatment of Type 2 Diabetes - Related Resources
DPP-4 inhibitors Antidiabetic Drugs: Oral Drugs and Incretin Mimetics - Quick Reference Dipeptidyl Peptidase-4 (Dpp-4) Inhibitors for Type 2 Diabetes Mellitus Glucagon-Like Peptide Analogues (GLP-1 Analogues) for Type 2 Diabetes Incretin-Based Therapy with Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes Insulin Added on Metformin in Type 2 Diabetes Meglitinide Analogues (Glinides) for Type 2 Diabetes Mellitus Oral Antidiabetic Drugs and GLP-1 Analogues in the Treatment of Type 2 Diabetes - Related Resources Pioglitazone for Type 2 Diabetes Mellitus Sglt-2 Inhibitors and GLP-1 Agonists for Diabetes and Chronic Kidney Disease Sglt-2 Inhibitors in Type 2 Diabetes Sulphonylurea for Type 2 Diabetes
DPP-4-inhibitors